Member Portal
About ISCTM
Mission Statement and Rationale
Objectives of the Society
Conflict of Interest Policy
ISCTM Strategic Plan
Executive Viewpoint
Committees
2026-2027 Executive Committee
2026-2027 Organizational Committees
Award Recipients
Code of Conduct
Society Amended and Restated Bylaws
Meetings / Activities
ISCTM Session Proposal Submission
2026 Autumn Conference
22nd Annual Scientific Meeting
Meeting Archives
Working Groups
Podcasts
Awards
Webinars
Upcoming Calendar
Related Meetings & Events
Support an ISCTM Meeting
Publications
Membership
Young Investigators
Benefits of Membership
Join/Renew Membership (Individual)
Individual Membership Categories & Dues
Sustaining Corporate Membership
2026 Sustaining Corporate Members
Benefits and Membership Levels
Member Directory
Update Profile
2021 Autumn Conference Posters
Click title to view pdf. Posters are listed in alpha order by first author.
Use of a pharmacogenomic biomarker to retarget a failed clinical trial with DB104 (Liafensine) in depression
(
Abstract
)
Alphs
Subjective cognitive decline and cognitive task performance: patient selection via social media and digital assessment validity
(
Abstract
)
Bilderbeck
Should placebo responders be excluded from RCTs?
(
Abstract
)
Branders
Efficient assessment of emotional bias using item response theory and decision tree computerised adaptive testing
(
Abstract
)
Cormack
M – Measuring within-child change in treatment studies of low-functioning children
(
Abstract
)
Daniel
D – Assessing the severity of anxiety symptoms at study entry into acute schizophrenia clinical trials
(
Abstract
)
Daniel
Investigating the proper adaptation of sleep scoring algorithms for pediatric trials
(
Abstract
)
Dorffner
Charting the proteome landscape in major psychiatric disorders: From biomarkers to biological pathways to precise drug development
(
Abstract
)
Fernandes
Qualitative analysis of the content validity of the Virtual Reality Functional Capacity Assessment Tool (VRFCAT) in schizophrenia An FDA-funded study
(
Abstract
)
Horan
Multimodal AI based facial and acoustic biomarkers of negative symptoms in schizophrenia
(
Abstract
)
Khan
Exploring discordant data in dementia clinical trials
(
Abstract
)
Kott
Positive and negative symptom predominance in the screening period in acute schizophrenia trials: An exploratory analysis
(
Abstract
)
Kott
Borderline across borderlines: Regional variation in who enters clinical trials
(
Abstract
)
Micaletto
Impact of protocol design on between scale discrepancies in early AD clinical trials
(
Abstract
)
Miller
Placebo Response Propensity Scale PRPS scores and probability of placebo response by disease severity
(
Abstract
)
Morlock
Application of a novel analytic methodology to improve PANSS data quality and signal detection in a global clinical trial of schizophrenia
(
Abstract
)
Opler
Scoring consistency checks for the Clinician Administered PTSD Scale CAPS
(
Abstract
)
Rabinowitz
PORTICO – A case study in overcoming methodological challenges in borderline personality disorder clinical development
(
Abstract
)
Ropacki
Monitoring of scale administration and videography improves quality in a study of a rare genetic neuromuscular disease
(
Abstract
)
Roy
Methodological approaches to outliers in cognitive assessment for schizophrenia: A post-hoc analysis of the EMERGENT-1 study
(
Abstract
)
Sauder
Thalamic structure and function in youth with and at familial risk for bipolar disorder
(
Abstract
)
Singh
Is elevating BHB by a ketone ester supplement sufficient in reducing alcohol craving and consumption in alcohol use disorder?
(
Abstract
)
Wiers
Search Posters
Not a Member Yet?
Some of the member benefits you could be receiving: Discounted Registration Fees; Access to the DocMatter Community; Access to archived meeting materials; Participation in ISCTM Working Groups
Join Today